Immune Pathways Help Identify Patients with Cancer and HIV Most Likely to Experience Reservoir Decay with Anti-PD1 Therapy By Ogkologos - March 9, 2026 47 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from multiomic profiling in the CITN-12 study Source RELATED ARTICLESMORE FROM AUTHOR 2026 ESMO Breast Cancer Award Recipient Announced Solid Organ Transplant Recipients with Pretransplant Cancer Have an Elevated Risk of Posttransplant Cancer of the Same Cancer Type Population-based lung cancer screening can reduce mortality in people who have never smoked, study shows in China MOST POPULAR It’s a fair COP: Why our chief clinician went to a... December 13, 2021 ΚΑΡΚΙΝΟΣ ΤΟΥ ΠΝΕΥΜΟΝΑ:ΝΕΑ ΜΕΛΕΤΗ, ΝΕΕΣ ΕΛΠΙΔΕΣ December 27, 2018 Longer PFS in Patients with Advanced Melanoma Treated with TILs than... December 14, 2022 Stimulating the Immune System Shrinks Some Slow-Growing Lymphomas September 26, 2018 Load more HOT NEWS How to Maintain Your Sexual Health During and After Lung Cancer The IGCCCG Update Model Allows Improved and More Granular Individual Prognostic... Rebuilding My Life After Cancer and Intensive Treatment: A Survivor’s Story New study to detect oesophageal cancer earlier
